|1.||Kunz, Horst: 6 articles (02/2014 - 11/2005)|
|2.||Danishefsky, Samuel J: 3 articles (10/2008 - 10/2003)|
|3.||Lightowlers, M W: 3 articles (01/2006 - 11/2001)|
|4.||Yusibov, Vidadi: 2 articles (06/2015 - 01/2013)|
|5.||Stock, Ingo: 2 articles (12/2014 - 09/2014)|
|6.||Li, Yan-Mei: 2 articles (02/2014 - 05/2010)|
|7.||Cai, Hui: 2 articles (02/2014 - 05/2010)|
|8.||Sung, Heungsup: 2 articles (02/2014 - 11/2010)|
|9.||Schleiss, Mark R: 2 articles (02/2014 - 11/2010)|
|10.||Esteban, Mariano: 2 articles (03/2013 - 08/2007)|
01/01/2006 - "Recombinant vaccines have been developed which are highly effective in preventing infection with Taenia ovis in sheep, Taenia saginata in cattle, Taenia solium in pigs and Echinococcus granulosus in livestock animals. "
09/29/2000 - "Immunogenic efficacy of differently produced recombinant vaccines candidates against Pseudomonas aeruginosa infections."
01/01/1991 - "Cell mediated and humoral immune protection against virus infections are discussed in relation to development and use of recombinant vaccines in the murine lymphocytic choriomeningitis virus infection. "
02/01/2014 - "These analyses support the study of PC-based recombinant vaccines in the GPCMV congenital infection model. "
09/15/1990 - "In initial human trials, synthetic vaccines have induced humoral immunity sufficient to prevent clinical infection in some cases and delay it in others. "
01/01/2000 - "These studies thus form the rationale to use such replication-deficient recombinant vaccines in future cancer vaccine trials."
11/27/2015 - "For example, Vaxvec includes 63 poxvirus-based recombinant vaccines for over 20 pathogens and cancers. "
01/01/2014 - "These data indicate the feasibility of the application of this new class of immunogens based on VEL concept as an alternative approach for the development of molecular vaccines against cancer. "
10/01/2013 - "He has recently been working on the design and characterization of recombinant vaccines for cancer therapy. "
11/01/2012 - "To overcome the problem, a new immunotherapeutic strategy combining synthetic vaccines made of artificial TACA derivatives and metabolic glycoengineering of cancer cells to express the artificial TACA derivatives was explored. "
08/01/2006 - "These studies open the avenues to understand the process of protein folding and secretory pathway in malaria parasites that in turn might aid in the production of superior recombinant vaccines and provide novel drug targets."
01/01/2001 - "The current phase I trial suggests that polyoximes may prove useful for the development of highly immunogenic, multicomponent synthetic vaccines for malaria, as well as for other pathogens."
01/01/1990 - "Recombinant vaccines in vitro, in vivo and synthetized are under study and provide the best prospects regarding immunization against human malaria."
01/01/2010 - "Molecular vaccines for malaria."
02/01/2005 - "Understanding the protective mechanism in the liver induced by recombinant vaccines against the pre-erythrocytic stages of malaria is important for vaccine development. "
|4.||Communicable Diseases (Infectious Diseases)
01/01/2013 - "These results support the evaluation of Pfs25-CP VLP as a potential TBV candidate and the feasibility of the 'launch' vector technology for the production of VLP-based recombinant vaccines against infectious diseases. "
01/01/2010 - "Synthetic vaccines constitute the most promising tools for controlling and preventing infectious diseases. "
01/01/2000 - "Based on such considerations, synthetic vaccines against infectious diseases may be constructed. "
01/01/1989 - "Recombinant vaccines are potentially extremely valuable instruments in the fight against infectious diseases, but caution is needed in their deployment. "
01/01/1989 - "The use of synthetic antigens for diagnosis of infectious diseases. "
11/01/1997 - "[The efficacy of recombinant vaccines against hepatitis B and the results of their use in a schedule for pediatric prophylactic inoculations]."
01/01/2010 - "Induced HBs antigenemia in healthy adults after immunization with two different hepatitis B recombinant vaccines."
01/01/2007 - "[Humoral immunological response in laboratory animals after vaccination with recombinant vaccines against viral hepatitis B of different generations]."
12/01/2004 - "Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B."
05/01/2002 - "[The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2]."
|5.||T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
|6.||Japanese Encephalitis Vaccines
|9.||Biological Markers (Surrogate Marker)
|10.||Monophenol Monooxygenase (Tyrosinase)
|2.||Tubal Sterilization (Tubal Ligation)
|3.||Transplantation (Transplant Recipients)